MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Abbott Laboratories

Closed

SectorHealthcare

132.08 0.37

Overview

Share price change

24h

Current

Min

129.76

Max

132.11

Key metrics

By Trading Economics

Income

7.6B

9.2B

Sales

339M

11B

P/E

Sector Avg

17.363

63.778

EPS

1.34

Dividend yield

1.78

Profit margin

84.099

Employees

114,000

EBITDA

82M

3B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+6.47% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.78%

2.39%

Next Earnings

16 kwi 2025

Next Dividend date

15 maj 2025

Next Ex Dividend date

15 kwi 2025

Market Stats

By TradingEconomics

Market Cap

7.8B

230B

Previous open

131.71

Previous close

132.08

News Sentiment

By Acuity

27%

73%

81 / 386 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Abbott Laboratories Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

22 sty 2025, 19:03 UTC

Earnings

Correction to Abbott Labs 4Q Sales Just Miss Estimates Article

22 sty 2025, 18:20 UTC

Earnings

Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update

22 sty 2025, 12:45 UTC

Earnings

Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales

1 lis 2024, 14:15 UTC

Major Market Movers

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win -- Update

1 lis 2024, 10:10 UTC

Major Market Movers

Reckitt Shares Surge After Baby Formula Lawsuit Win

31 paź 2024, 23:57 UTC

Hot Stocks

Stocks to Watch: Intel, Amazon.com, Abbott Laboratories, MasTec

31 paź 2024, 23:14 UTC

Major Market Movers

Abbott Laboratories Shares Rise After Baby-Formula Verdict

16 paź 2024, 12:03 UTC

Earnings

Abbott Laboratories 3Q Sales Top Expectations

1 lut 2025, 18:14 UTC

Top News

Musk's X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit -- WSJ

22 sty 2025, 16:40 UTC

Top News
Earnings

Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. -- Barrons.com

22 sty 2025, 15:20 UTC

Earnings

Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine -- IBD

22 sty 2025, 15:08 UTC

Earnings

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 sty 2025, 13:51 UTC

Earnings

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit -- IBD

22 sty 2025, 13:39 UTC

Top News
Earnings

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 sty 2025, 12:02 UTC

Earnings

Abbott Labs Sees 1Q Adj EPS $1.05-Adj EPS $1.09 >ABT

22 sty 2025, 12:01 UTC

Earnings

Abbott Labs Sees 2025 Adj EPS $5.05-Adj EPS $5.25 >ABT

22 sty 2025, 12:01 UTC

Earnings

Abbott Labs Sees 2025 Adjusted Operating Margin 23.5%-24% >ABT

22 sty 2025, 12:00 UTC

Earnings

Abbott Labs Sees 2025 Organic Sales Growth 7.5%-8.5% >ABT

22 sty 2025, 12:00 UTC

Earnings

Abbott Labs 4Q Net $9.23B >ABT

22 sty 2025, 12:00 UTC

Earnings

Abbott Labs 4Q Sales $10.97B >ABT

22 sty 2025, 12:00 UTC

Earnings

Abbott Labs 4Q Organic Sales Growth Up 8.8% >ABT

22 sty 2025, 12:00 UTC

Earnings

Abbott Labs 4Q EPS $5.27 >ABT

22 sty 2025, 12:00 UTC

Earnings

Abbott Labs 4Q Adj EPS $1.34 >ABT

22 sty 2025, 09:54 UTC

Hot Stocks

Stocks to Watch Wednesday: Netflix, Oracle, Trump Media, Softbank -- WSJ

1 lis 2024, 17:33 UTC

Market Talk

Abbott's Baby-Formula Lawsuit Win Could Decrease Liabilities -- Market Talk

16 paź 2024, 14:21 UTC

Top News
Earnings

Abbott Posts Solid Quarter. The Stock Is Rising. -- Barrons.com

16 paź 2024, 12:25 UTC

Earnings

Abbott Labs Beats Q3 Sales And Earnings Expectations, Raises Full-Year Outlook -- MarketWatch

16 paź 2024, 12:02 UTC

Top News
Earnings

Abbott Posts Solid Quarter. That Wasn't Enough to Lift Shares. -- Barrons.com

16 paź 2024, 11:59 UTC

Earnings

Abbott Earnings Edge Past Q3 Views, Led By Medical Devices -- IBD

16 paź 2024, 11:37 UTC

Earnings

Abbott Labs Sees 4Q Adj EPS $1.31-Adj EPS $1.37 >ABT

Peer Comparison

Price change

Abbott Laboratories Forecast

Price Target

By TipRanks

6.47% upside

12 Months Forecast

Average 140.21 USD  6.47%

High 158 USD

Low 117 USD

Based on 16 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

14

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

126.3 / 133.46Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

81 / 386 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.